Tumori Journal – Author's Insight A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial

<p class="MsoListParagraph"><span lang="EN-GB" xml:lang="EN-GB">In this podcast, Dr. Alberto G Leone discusses about the most relevant findings about cancer care among transgender and gender-diverse individuals: the argument has been recently summarized in a literature review, published in Jama Oncology, with the aim to identify areas of gaps and unmet needs, to highlight priority areas and outline policy solutions and clinical recommendations. The article is available here <span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-ansi-language: EN-GB; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;" xml:lang="EN-GB"><a href= "https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fjournals.sagepub.com%2Fdoi%2Ffull%2F10.1177%2F03008916221138881&data=05%7C01%7Carundev.das%40sagepub.in%7Ce87bc74ffef44debc87f08db292cd44b%7C866b3abd7515461abdb412b4a1857f04%7C0%7C0%7C638149044756276386%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=xwgYc1wtvzrkeqmeieps%2FSaQuGRvjFu42McyS1jn230%3D&reserved=0"> https://journals.sagepub.com/doi/full/10.1177/03008916221138881</a></span></span></p>